1Manning AP,Thompson WG,Heaton KW,et al.Towards positive diagnosis of the irritable bowel[J].Br Med J,1978,2 (6138):653-654. 被引量：1
2Prior A,Wilson KM,Whorwell PJ.Double-blind study of an alpha 2 agonist in the treatment of irritable bowel syndrome[J].Aliment Pharmacol Ther,1988,2(6):535-539. 被引量：1
3Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process[J].Gastroenterololgy,2006,130(5):1377-1390. 被引量：1
4Gonsalkorale WM,Perrey C,Pravica V,et al.Interleukin 10 genotypes in irritable bowel syndrome; evidence for an inflammatory component[J].Gut,2003,52(1):91-93. 被引量：1
5Ware NC,Kleinman A.Culture and somatie experience:the social course of illness in neurasthenia and chronic fatigue syndrome[J].Psychosom Med,1992,54(5):546-560. 被引量：1
6Drossman DA,Li Z,Andruzzi E,et al.U.S.householder survey of functional gastrointestinal disorders.Prevalence,sociodemography,and health impant[J].Dig Dis Sci,1993,38(9):1569-1580. 被引量：1
7Simren M,Abrahamsson H,Svedland J,et al.Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care:the impact of gender and predominant bowel pottern[J].Scand J Gastroenterol,2001,36(5):545-552. 被引量：1
